Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type I b patient
Glycogen storage disease type I b ( GSDI b) is caused by a deficiency in the glucose‐6‐phosphate transporter ( G 6 PT ), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem c...
Saved in:
Published in | Genes to cells : devoted to molecular & cellular mechanisms Vol. 18; no. 12; pp. 1053 - 1069 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.12.2013
|
Online Access | Get full text |
Cover
Loading…
Summary: | Glycogen storage disease type
I
b (
GSDI
b) is caused by a deficiency in the glucose‐6‐phosphate transporter (
G
6
PT
), which leads to neutrophil dysfunction. However, the underlying causes of these dysfunctions and their relationship with glucose homeostasis are unclear. Induced pluripotent stem cells (i
PSC
s) hold a great promise for advances in developmental biology, cell‐based therapy and modeling of human disease. Here, we examined the use of i
PSC
s as a model for
GSDI
b. In this study, one 2‐year‐old patient was genetically screened and diagnosed with
GSDI
b. We established i
PSC
s and differentiated these cells into hepatocytes and neutrophils, which comprise the main pathological components of
GSDI
b. Cells that differentiated into hepatocytes exhibited characteristic albumin secretion and indocyanine green uptake. Moreover, i
PSC
‐derived cells generated from patients with
GSDI
b metabolic abnormalities recapitulated key pathological features of the diseases affecting the patients from whom they were derived, such as glycogen, lactate, pyruvate and lipid accumulation. Cells that were differentiated into neutrophils also showed the
GSDI
b pathology. In addition to the expression of neutrophil markers, we showed increased superoxide anion production, increased annexin
V
binding and activation of caspase‐3 and caspase‐9, consistent with the
GSDI
b patient's neutrophils. These results indicate valuable tools for the analysis of this pathology and the development of future treatments. |
---|---|
ISSN: | 1356-9597 1365-2443 |
DOI: | 10.1111/gtc.12101 |